Congratulations to Susan Solomon, GAiT Director and CEO of @NYSCF, for winning the @ISSCR Stem Cell Public Service Award
Susan L. Solomon Receives Public Service Award From International Society for Stem Cell Research - New York Stem Cell Foundation
NYSCF CEO Susan L. Solomon recently received the 2020 Public Service Award from the International Society for Stem Cell...
nyscf.org
ISCT2020, initially planned as a traditional conference in Paris, will now be held as virtual meeting instead on the same dates.
ISCT transitions to a virtual conference amidst coronavirus concerns
The International Society for Cell and Gene Therapy (ISCT; BC, Canada) has decided to alter their globally attended conference (27–30 May 2020, Pari...
www.regmednet.com
Regenerative Medicine's infographic showing recommended standards for clinical grade iPSCs for therapeutic development is now online:
Minimum standards for clinical iPSCs: what the experts suggest
In this infographic, we summarize key clinical standards suggested by the experts involved in the GAiT global banking network, as described in their R...
www.regmednet.com
GAiT Chairperson Prof Marc Turner will be speaking on GAiT activity in London 30th March - 1st April at the Terrapin 'Advanced Therapies Congress and Expo'
Research. Develop. Collaborate. Commercialise | Advanced Therapies
The global marketplace for investment, commercial opportunities and collaboration in the advanced therapies and regenerative medicine space.
www.terrapinn.com
A report released by the @CGTCatapult states that employment in the UK cell and gene therapy industry is set to double by 2024 the report indicates there are concerns over how demand will be met; primarily, the availability of targeted academic courses
Demand for ‘specialist skills’ in UK cell and gene therapy, says report
A skills demand report stated that employment in the UK cell and gene therapy industry is expected to double by 2024, with support of targeted courses...
www.europeanpharmaceuticalreview.com
Osaka University transplants iPS cell-based heart cells in world's first clinical trial
Osaka University transplants iPS cell-based heart cells in world's first clinical trial | The Japan Times
An Osaka University team said it has carried out the world's first transplant of cardiac muscle cells created from iPS cells in a physician-initiated ...
www.japantimes.co.jp
